
H. Lundbeck A/S
H. Lundbeck A/S (HLBBF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HLBBF · as of Jun 9, 2026
Key Statistics
Explore H. Lundbeck A/S Data
hlbbf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hlbbf competitorsStock Performance
Full HistoryAbout H. Lundbeck A/S
H. Lundbeck A/S operates as an international biopharmaceutical entity, focusing its efforts on the entire lifecycle of pharmaceutical products—from initial research and development to manufacturing an…
what is h. lundbeck a/s · hlbbf stock overview · h. lundbeck a/s company profile · who is h. lundbeck a/s ceo · hlbbf OTC · h. lundbeck a/s headquarters · h. lundbeck a/s business segments
About Stock Overview & Key Data
H. Lundbeck A/S (HLBBF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jul 13, 2022. As of the latest trading session, HLBBF stock price is $7.29, with a market capitalization of $5.8B. The stock has returned +27.00% over the past 12 months and +6.27% year-to-date.
In fiscal year 2025, H. Lundbeck A/S reported revenue of $24.3B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, H. Lundbeck A/S (HLBBF) stock price is $7.29. The stock is traded on OTC under the ticker symbol HLBBF. The 52-week range is $4.42 – $7.55.